Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes
- PMID: 20973725
- DOI: 10.1086/657135
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes
Abstract
Objective: To determine risk factors for bloodstream infections (BSIs) caused by Klebsiella pneumoniae producing metallo-β-lactamases (MBLs) or K. pneumoniae carbapenemases (KPCs), as well as risk factors for mortality associated with carbapenem-resistant K. pneumoniae, among intensive care unit (ICU) patients.
Methods: Two case-control studies were conducted in a patient cohort with K. pneumoniae BSIs in an 8-bed ICU in a Greek hospital from January 1, 2007, through December 31, 2008. In study 1, patients with K. pneumoniae BSIs were allocated among 3 groups according to isolate susceptibility profile: (1) carbapenem-susceptible insolates (control group), (2) MBL-producing isolates, or (3) KPC-producing isolates. The MBL and KPC groups were compared with the control group to identify risk factors for development of K. pneumoniae BSI. In study 2, patients with K. pneumoniae BSIs who died were compared with survivors to identify risk factors for mortality.
Results: Fifty-nine patients had K. pneumoniae BSIs (22 with carbapenem-susceptible isolates, 18 with MBL-producing isolates, and 19 with KPC-producing isolates). All KPC-producing isolates carried the bla(KPC-2) gene, and 17 of 18 MBL-producing isolates carried bla(VIM-1). Acute Physiology and Chronic Health Evaluation II score (odds ratio, 1.13 [95% confidence interval, 1.03-1.25]; [Formula: see text]) was independently associated with KPC-producing K. pneumoniae BSIs. Nine (41%) of 22 control patients, 8 (44%) of 18 MBL group patients, and 13 (68%) of 19 KPC group patients died in the ICU. Nine (41%) of 22 control patients, 10 (56%) of 18 MBL group patients, and 15 (79%) of 19 KPC group patients died in the hospital. Isolation of KPC-producing K. pneumoniae was an independent predictor of ICU death ([Formula: see text]) and in-hospital death ([Formula: see text]) but not infection-attributable death.
Conclusions: BSIs due to KPC-producing K. pneumoniae resulted in significantly increased mortality. The accurate and rapid detection of these pathogens is necessary for therapeutic considerations and for the implementation of infection control measures to contain them.
Similar articles
-
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.Scand J Infect Dis. 2014 Sep;46(9):642-8. doi: 10.3109/00365548.2014.923106. Epub 2014 Jul 14. Scand J Infect Dis. 2014. PMID: 25017796
-
An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.Clin Infect Dis. 2010 Feb 1;50(3):364-73. doi: 10.1086/649865. Clin Infect Dis. 2010. PMID: 20041768
-
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.J Hosp Infect. 2010 Sep;76(1):70-3. doi: 10.1016/j.jhin.2010.03.021. Epub 2010 Jun 17. J Hosp Infect. 2010. PMID: 20705205
-
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.Expert Rev Anti Infect Ther. 2013 Oct;11(10):1053-63. doi: 10.1586/14787210.2013.836057. Epub 2013 Sep 27. Expert Rev Anti Infect Ther. 2013. PMID: 24073806 Review.
-
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.Lancet Infect Dis. 2009 Apr;9(4):228-36. doi: 10.1016/S1473-3099(09)70054-4. Lancet Infect Dis. 2009. PMID: 19324295 Review.
Cited by
-
The role of antimicrobial resistance on long-term mortality and quality of life in critically ill patients: a prospective longitudinal 2-year study.Health Qual Life Outcomes. 2021 Mar 3;19(1):72. doi: 10.1186/s12955-021-01712-0. Health Qual Life Outcomes. 2021. PMID: 33658021 Free PMC article.
-
Comorbidities and disease severity as risk factors for carbapenem-resistant Klebsiella pneumoniae colonization: report of an experience in an internal medicine unit.PLoS One. 2014 Oct 15;9(10):e110001. doi: 10.1371/journal.pone.0110001. eCollection 2014. PLoS One. 2014. PMID: 25335100 Free PMC article.
-
Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype.Antimicrob Agents Chemother. 2015 Nov;59(11):7036-43. doi: 10.1128/AAC.01405-15. Epub 2015 Sep 8. Antimicrob Agents Chemother. 2015. PMID: 26349819 Free PMC article.
-
Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1125-1131. doi: 10.1007/s10096-017-2899-6. Epub 2017 Jan 19. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28102514
-
Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis.Braz J Infect Dis. 2015 Mar-Apr;19(2):170-80. doi: 10.1016/j.bjid.2014.12.004. Epub 2015 Jan 28. Braz J Infect Dis. 2015. PMID: 25636193 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous